30 Day Trial

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Musculoskeletal New Ventures Conference to Offer Insights on Funding and Startup Climate

Orthopaedic professionals can expect to hear about technologies being commercialized by 22 companies along with insight from long-term investors during the conference, held October 23-24 in Memphis, Tennessee. 

Spine Company Sales: ORTHOWORLD Top Ten

Downloadable resource on the top 10 players in spine.

Spine Market Growth Expected to Remain at 2%

Spine accounts for 18% of the orthopaedic industry’s overall revenue. In 2017, sales of spine products (excluding biologics) exceeded $9 billion worldwide, an increase of 2.2% vs. 2016, according to our estimates. The segment remains a story of large, differentiated companies losing market share to the players that derive the majority of their revenue from spine.

The Future of Spine Care: Rethinking Collaboration Among Hospitals, Physicians and OEMs

The future for spine care is bright, but will require strategically rethinking traditional business practices with a greater emphasis on collaboration and more intimately understanding the respective products, services and goals for each stakeholder: providers, physicians and OEMs.

Spine Merger & Acquisition Activity Going Strong

With 1H18 spine revenue growth reporting all over the board, and still without concrete consensus from companies and analysts on the state and future of the segment, I got really curious about M&A transactions in the space. What have companies done to purchase what they needed or divest what wasn’t working?

Page Navigation